Ann: FDA Clearance Granted for VascuCel-AHZ.AX, page-314

I doubt there will be another cr. they have quite a bit of cash now and the gap between income and expenditure is closing all the time. You can never be sure but I think it very unlikely they will have to raise more dough.

The management are focussed on cost cutting and I think it likely they will achieve break even before 2018. It depends how well the new product goes from mob launch of course. I am a Johnny come lately to this stock but I was amazed to see how close to being profitable they are.

Does anyone know if the new product will be much more expensive than what is currently being used? If it is a lot more expensive that might slow market penetration.

Just a guess but I think it might creep higher this afternoon. Also just an opinion but I think the massive volume is more likely due solely to traders than to a new big holder.